MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

MSD is expecting to see an additional $200 million layered onto its costs this year as a result of President Trump's tariffs – even before a possible pharma-specific levy is announced. The US pharma ...

Japanese chip distributor Macnica Holdings Inc. plans to expand its presence in fast-growing regions, including China and Southeast Asia. This is reported in a Macnica press release. Through the ...